Mitotech SA
Vallee, LU· latest recorded location
MITOTECH SA is named on 17 US grants and 26 published applications in this corpus. Its most frequent classification is A61K (Medicines and medical preparations).
- Granted patents
- 17
- Published applications
- 26
- Inventors
- 36
- Granted in 2026 so far
- 0
- Most recent grant
- 26 Feb 2019
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2010 | 0 | 3 |
| 2011 | 0 | 3 |
| 2012 | 0 | 2 |
| 2013 | 3 | 2 |
| 2014 | 1 | 2 |
| 2015 | 1 | 1 |
| 2016 | 6 | 6 |
| 2017 | 4 | 1 |
| 2018 | 0 | 1 |
| 2019 | 2 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 1 |
| 2022 | 0 | 0 |
| 2023 | 0 | 2 |
| 2024 | 0 | 1 |
| 2025 | 0 | 0 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Technology areas
Share of 43 documents
- A61KMedicines and medical preparations39
- A61PTherapeutic uses of medicines37
- C09BOrganic dyes or closely-related compounds for producing dyes21
- C07DHeterocyclic compounds6
- C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen6
- A61QSpecific use of cosmetics or similar toiletry preparations4
- A01NPreservation of bodies of humans or animals or plants or parts thereof2
- A61LMethods or apparatus for sterilising materials or objects in general2
- C07CAcyclic or carbocyclic compounds2
- C11DDetergent compositions2
Recent patents
- Pharmaceutical composition for use in medical and veterinary ophthalmology26 Feb 2019US 10,213,392 B2
- Mitochondria-targeted antioxidants for treatment of age-related brain disorders29 Jan 2019US 10,188,669 B2
- Pharmaceutical formulations containing mitochondrially targeted antioxidants29 Aug 2017US 9,744,180 B2
- Pharmaceutical composition for use in medical and veterinary ophthalmology8 Aug 2017US 9,724,313 B2
- Pharmaceutical compositions for preventing and treating eye pathologies21 Feb 2017US 9,572,821 B2
- Treatment of Dry Eye Disease Using Mitochondrially Targeted Antioxidants12 Mar 2026US 2026/0069619 A1
- Contact Lenses And Other Eye-Contacting Matrices Carrying Mitochondrially-Targeted Antioxidants11 Jul 2024US 2024/0226001 A1
- Use of Mitochondria-Targeted Antioxidants to Treat Severe Inflammatory Conditions15 Jun 2023US 2023/0181604 A1
- Polymer matrixes for different compositions of mitochondrially targeted antioxidants9 Feb 2023US 2023/0038070 A1
- A set of mitochondria-targeted compounds12 Aug 2021US 2021/0246144 A1
Most cited
By later US patents
- Use of mitochondrially-addressed compounds for preventing and treating cardiovascular diseases2US 8,518,915 B22013
- Pharmaceutical substances on the basis of mitochondria-addressed antioxidants2US 9,233,903 B22016
- Pharmaceutical compositions useful for preventing and treating cancer2US 9,408,859 B22016
- Mitochondria-targeted antioxidants for treatment of age-related brain disorders1US 10,188,669 B22019
- Pharmaceutical compositions useful for preventing and treating oncological diseases1US 8,349,902 B22013